Episodes 76-90 of 600
Detecting Metastatic Breast Cancer: The Role of Scans and Emerging Blood Tests
Project Oncology®Detecting Metastatic Breast Cancer: The Role of Scans and Emerging Blood Tests
Emerging Metastatic Breast Cancer Therapies: From CDK Inhibitors to SERDs and Beyond
Project Oncology®Emerging Metastatic Breast Cancer Therapies: From CDK Inhibitors to SERDs and Beyond
Breast Cancer Care Advancements: Using AI to Detect Lymph Node Metastasis
Project Oncology®Breast Cancer Care Advancements: Using AI to Detect Lymph Node Metastasis
Managing High-Risk Myeloma: From Cytogenetic Abnormalities to Therapeutic Approaches
Project Oncology®Managing High-Risk Myeloma: From Cytogenetic Abnormalities to Therapeutic Approaches
Risk Stratification Models for Precursor Diseases in Multiple Myeloma
Project Oncology®Risk Stratification Models for Precursor Diseases in Multiple Myeloma
From MGUS to Multiple Myeloma: Understanding the Progression of Precursor Diseases
Project Oncology®From MGUS to Multiple Myeloma: Understanding the Progression of Precursor Diseases
Optimizing the Screening of Precursor Diseases in Multiple Myeloma
Project Oncology®Optimizing the Screening of Precursor Diseases in Multiple Myeloma
Optimizing Multiple Myeloma Care: Advances for Newly Diagnosed Patients
Project Oncology®Optimizing Multiple Myeloma Care: Advances for Newly Diagnosed Patients
Artificial Intelligence for Cancer Detection: The Next Frontier in Oncology
Clinician's RoundtableArtificial Intelligence for Cancer Detection: The Next Frontier in Oncology
Artificial Intelligence in Medicine: 5 Key Issues Physicians Are Facing
Clinician's RoundtableArtificial Intelligence in Medicine: 5 Key Issues Physicians Are Facing
Insights from ICARUS-Lung01: Efficacy and Safety of Dato-DXd for NSCLC
On the Frontlines of Non-Small Cell Lung CancerInsights from ICARUS-Lung01: Efficacy and Safety of Dato-DXd for NSCLC
Poster Pearl: Dato-DXd Demonstrates Intracranial Efficacy in NSCLC
On the Frontlines of Non-Small Cell Lung CancerPoster Pearl: Dato-DXd Demonstrates Intracranial Efficacy in NSCLC
Myeloma Matters: Bispecific Antibody Horizons: Dosing Strategies and Meeting Updates in Myeloma Care
Project Oncology®Myeloma Matters: Bispecific Antibody Horizons: Dosing Strategies and Meeting Updates in Myeloma Care
T-Cell Characteristics: Key Players in Bispecific Antibody Treatment Success
Project Oncology®T-Cell Characteristics: Key Players in Bispecific Antibody Treatment Success
Uncovering New Biomarkers for RCC: A Review of Emerging Techniques
Project Oncology®Uncovering New Biomarkers for RCC: A Review of Emerging Techniques
